Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling

Clinical Immunology

Volumn 164, Issue , 2016, Pages 57-64

  Pang, Xiaoli ^a   Song, Hongxiao ^a   Zhang, Qianqian ^a   Tu, Zhengkun ^a   Niu, Junqi ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Autocrine cytokine; Hepatitis C virus; Monocytic myeloid derived suppressor cell; Peripheral blood mononuclear cell; PI3K pathway

Indexed keywords

CD14 ANTIGEN; CORE PROTEIN; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; PHOSPHATIDYLINOSITOL 3 KINASE; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS;

ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; CELL PROLIFERATION; CYTOLOGY; HEPACIVIRUS; HEPATITIS C; IMMUNOLOGY; MONONUCLEAR CELL;

AUTOCRINE COMMUNICATION; CELL PROLIFERATION; CYTOKINES; HEPACIVIRUS; HEPATITIS C; HUMANS; LEUKOCYTES, MONONUCLEAR; PHOSPHATIDYLINOSITOL 3-KINASES; POLY I-C; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

EID: 84958012471     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2016.01.014     Document Type: Article

References (42)

1. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 2001, 345:41-52.
2. Dustin L.B., Rice C.M. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 2007, 25:71-99.
3. Bronte V., Apolloni E., Cabrelle A., Ronca R., Serafini P., Zamboni P., Restifo N.P., Zanovello P. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 2000, 96:3838-3846.
4. Talmadge J.E., Gabrilovich D.I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer 2013, 13:739-752.
5. Porembka M.R., Mitchem J.B., Belt B.A., Hsieh C.S., Lee H.M., Herndon J., Gillanders W.E., Linehan D.C., Goedegebuure P. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Cancer Immunol. Immunother. 2012, 61:1373-1385.
6. Korc M. Pancreatic cancer-associated stroma production. Am. J. Surg. 2007, 194:S84-S86.
7. Cai W., Qin A., Guo P., Yan D., Hu F., Yang Q., Xu M., Fu Y., Zhou J., Tang X. Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J. Clin. Immunol. 2013, 33:798-808.
8. Nonnenmann J., Stirner R., Roider J., Jung M.C., Schrödl K., Bogner J.R., Draenert R. Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals. J. Virol. 2014, 88:7678-7682.
9. Poschke I., Mougiakakos D., Hansson J., Masucci G.V., Kiessling R. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 2010, 70:4335-4345.
10. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
11. Hoechst B., Ormandy L.A., Ballmaier M., Lehner F., Krüger C., Manns M.P., Greten T.F., Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008, 135:234-243.
12. Loercher A.E., Nash M.A., Kavanagh J.J., Platsoucas C.D., Freedman R.S. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J. Immunol. 1999, 163:6251-6260.
13. MacDonald K.P., Rowe V., Clouston A.D., Welply J.K., Kuns R.D., Ferrara J.L., Thomas R., Hill G.R. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J. Immunol. 2005, 174:1841-1850.
14. Srivastava M.K., Sinha P., Clements V.K., Rodriguez P., Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 2010, 70:68-77.
15. Tu Z., Bozorgzadeh A., Crispe I.N., Orloff M.S. The activation state of human intrahepatic lymphocytes. Clin. Exp. Immunol. 2007, 149:186-193.
16. Tu Z., Bozorgzadeh A., Pierce R.H., Kurtis J., Crispe I.N., Orloff M.S. TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 2008, 205:233-244.
17. Dolganiuc A., Oak S., Kodys K., Golenbock D.T., Finberg R.W., Kurt-Jones E., Szabo G. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004, 127:1513-1524.
18. Düesberg U., von dem Bussche A., Kirschning C., Miyake K., Sauerbruch T., Spengler U. Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)-core protein is mediated by toll like receptors (TLRs) 2 and 4. Immunol. Lett. 2002, 84:89-95.
19. Foy E., Li K., Sumpter R., Loo Y.M., Johnson C.L., Wang C., Fish P.M., Yoneyama M., Fujita T., Lemon S.M., Gale M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-signaling. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2986-2991.
20. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
21. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale M., Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2992-2997.
22. Kotsakis A., Harasymczuk M., Schilling B., Georgoulias V., Argiris A., Whiteside T.L. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J. Immunol. Methods 2012, 381:14-22.
23. Trellakis S., Bruderek K., Hütte J., Elian M., Hoffmann T.K., Lang S., Brandau S. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer. Innate Immun. 2013, 19:328-336.
24. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 2009, 182:4499-4506.
25. Almand B., Clark J.I., Nikitina E., van Beynen J., English N.R., Knight S.C., Carbone D.P., Gabrilovich D.I. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 2001, 166:678-689.
26. Zea A.H., Rodriguez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta J., McDermott D., Qiuceno D., Youmans A., O'Neill A., Mier J., Ochoa A.C. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005, 65:3044-3048.
27. Löb S., Königsrainer A., Rammensee H.G., Opelz G., Terness P. Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?. Nat. Rev. Cancer 2009, 9:445-452.
28. Thibodeau J., Bourgeois-Daigneault M.C., Huppé G., Tremblay J., Aumont A., Houde M., Bartee E., Brunet A., Gauvreau M.E., De Gassart A., Gatti E., Baril M., Cloutier M., Bontron S., Früh K., Lamarre D., Steimle V. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur. J. Immunol. 2008, 38:1225-1230.
29. Lechner M.G., Liebertz D.J., Epstein A.L. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 2010, 185:2273-2284.
30. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., Calabrese F., Basso G., Zanovello P., Cozzi E., Mandruzzato S., Bronte V. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
31. Lechner M.G., Megiel C., Russell S.M., Bingham B., Arger N., Woo T., Epstein A.L. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J. Transl. Med. 2011, 9:90.
32. Lappat E.J., Cawein M. Study of the leukemoid response to transplantable a-280 tumor in mice. Cancer Res. 1964, 24:302-311.
33. Bunt S.K., Clements V.K., Hanson E.M., Sinha P., Ostrand-Rosenberg S. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J. Leukoc. Biol. 2009, 85:996-1004.
34. Hu C.E., Gan J., Zhang R.D., Cheng Y.R., Huang G.J. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scand. J. Gastroenterol. 2011, 46:156-164.
35. Donkor M.K., Lahue E., Hoke T.A., Shafer L.R., Coskun U., Solheim J.C., Gulen D., Bishay J., Talmadge J.E. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int. Immunopharmacol. 2009, 9:937-948.
36. Tacke R.S., Lee H.C., Goh C., Courtney J., Polyak S.J., Rosen H.R., Hahn Y.S. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 2012, 55:343-353.
37. Enioutina E.Y., Bareyan D., Daynes R.A. A role for immature myeloid cells in immune senescence. J. Immunol. 2011, 186:697-707.
38. Weichhart T., Costantino G., Poglitsch M., Rosner M., Zeyda M., Stuhlmeier K.M., Kolbe T., Stulnig T.M., Hörl W.H., Hengstschläger M., Müller M., Säemann M.D. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 2008, 29:565-577.
39. Ballou L.M., Lin R.Z. Rapamycin and mTOR kinase inhibitors. J. Chem. Biol. 2008, 1:27-36.
40. Tacke R.S., Tosello-Trampont A., Nguyen V., Mullins D.W., Hahn Y.S. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-autocrine pathway. J. Biol. Chem. 2011, 286:10847-10855.
41. Dolcetti L., Peranzoni E., Ugel S., Marigo I., Fernandez Gomez A., Mesa C., Geilich M., Winkels G., Traggiai E., Casati A., Grassi F., Bronte V. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010, 40:22-35.
42. Kwan W.H., Boix C., Gougelet N., Fridman W.H., Mueller C.G. LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursors. J. Leukoc. Biol. 2007, 82:133-141.